These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8959299)

  • 1. Zinc deficiency in attention-deficit hyperactivity disorder.
    Toren P; Eldar S; Sela BA; Wolmer L; Weitz R; Inbar D; Koren S; Reiss A; Weizman R; Laor N
    Biol Psychiatry; 1996 Dec; 40(12):1308-10. PubMed ID: 8959299
    [No Abstract]   [Full Text] [Related]  

  • 2. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Methylphenidate (Ritalin) treatment in attention deficit hyperactivity disorder].
    Shalev R; Gross-Tsur V
    Harefuah; 1997 May; 132(9):672-5. PubMed ID: 9225587
    [No Abstract]   [Full Text] [Related]  

  • 4. Hematologic and blood biochemistry monitoring during methylphenidate treatment in children with attention-deficit/hyperactivity disorder: 2-year, open-label study results.
    Wigal SB; Wilens TE; Wolraich M; Lerner M
    Pediatrics; 2007 Jul; 120(1):e120-8. PubMed ID: 17548486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attention deficit hyperactivity disorder, chronic tic disorder, and methylphenidate.
    Gadow KD; Sverd J
    Adv Neurol; 2006; 99():197-207. PubMed ID: 16536367
    [No Abstract]   [Full Text] [Related]  

  • 6. Attention-deficit hyperactivity disorder, methylphenidate, and primary encopresis.
    Golubchik P; Weizman A
    Psychosomatics; 2009; 50(2):178. PubMed ID: 19377031
    [No Abstract]   [Full Text] [Related]  

  • 7. Attention-deficit/hyperactivity disorder: advances in diagnostic and therapeutic approaches.
    DelBello MP
    J Clin Psychiatry; 2008 Jan; 69(1):130. PubMed ID: 18312047
    [No Abstract]   [Full Text] [Related]  

  • 8. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2006 Nov; 29(11):415-6. PubMed ID: 17131689
    [No Abstract]   [Full Text] [Related]  

  • 9. Zeroing in on attention deficit disorder.
    Health News; 1999 Feb; 5(2):7. PubMed ID: 9972114
    [No Abstract]   [Full Text] [Related]  

  • 10. Methylphenidate use for attention deficit hyperactivity disorder in northern Israel--a controversial issue.
    Fogelman Y; Kahan E
    Isr Med Assoc J; 2001 Dec; 3(12):925-7. PubMed ID: 11794916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased urine phenylethylamine after methylphenidate treatment in children with ADHD.
    Kusaga A; Yamashita Y; Koeda T; Hiratani M; Kaneko M; Yamada S; Matsuishi T
    Ann Neurol; 2002 Sep; 52(3):372-4. PubMed ID: 12205654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
    [No Abstract]   [Full Text] [Related]  

  • 13. Methylphenidate use and divorce.
    Schultz BK
    CMAJ; 2007 Sep; 177(7):751; author reply 751. PubMed ID: 17893352
    [No Abstract]   [Full Text] [Related]  

  • 14. An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder.
    Nikles CJ; Mitchell GK; Del Mar CB; Clavarino A; McNairn N
    Pediatrics; 2006 Jun; 117(6):2040-6. PubMed ID: 16740846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurogenetic determinism and the new euphenics. Child and adolescent psychiatrists use methylphenidate because it makes children better.
    Williams JH
    BMJ; 1999 May; 318(7196):1488-9. PubMed ID: 10419301
    [No Abstract]   [Full Text] [Related]  

  • 16. [The use of methylphenidate in children with ADHD].
    Lauth B
    Laeknabladid; 2007 Dec; 93(12):823. PubMed ID: 18057471
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of methylphenidate on time perception in children with attention-deficit/hyperactivity disorder.
    Baldwin RL; Chelonis JJ; Flake RA; Edwards MC; Feild CR; Meaux JB; Paule MG
    Exp Clin Psychopharmacol; 2004 Feb; 12(1):57-64. PubMed ID: 14769100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Attention deficit-hyperactivity disorder (ADHD); etiology, diagnosis and treatment].
    't Jong GW; van den Anker JN
    Ned Tijdschr Geneeskd; 2000 Nov; 144(46):2227-8. PubMed ID: 11103263
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of methylphenidate on word decoding accuracy in boys with attention-deficit/hyperactivity disorder.
    Bental B; Tirosh E
    J Clin Psychopharmacol; 2008 Feb; 28(1):89-92. PubMed ID: 18204348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neurology of attention deficit/hyperactivity disorder.
    Curatolo P
    Brain Dev; 2005 Dec; 27(8):541-3. PubMed ID: 16310587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.